跳至主要内容
临床试验/NCT00249587
NCT00249587已完成1 期

Medication Adherence Therapy for Opioid Abusing Pain Patients

National Institute on Drug Abuse (NIDA)1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2000年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
36
试验地点
1
主要终点
Medication compliance and unauthorized drug use

研究概览

简要总结

The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medication adherence.

详细描述

Project Pain is a Stage I behavioral therapies development project aimed at developing and pilot testing a novel intervention for patients with chronic non-malignant pain who have experienced difficulty managing prescribed opioids. The goals of the study are to: (1) develop the intervention and training materials; (2) develop therapist adherence and competence scales; (3) train therapists to deliver the intervention per the treatment protocol; and (4) pilot the intervention to assess its feasibility, acceptability and promise. The goals of the intervention are to: (1) improve adherence to prescribed opioids; (2) decrease the severity of patients' pain; and (3) improve patients' functioning and quality of life .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Uninterrupted pain of at least 6 months duration
  • Pain is continuous, rather than intermittent
  • Pain in the severe range (VAS = 7-10) while medicated
  • Poor response to non-pharmacological interventions for pain (if appropriate)
  • One or more of the following pain diagnoses: (a) back/neck pain; (b) myofacial pain; (c) neuropathic pain (e.g., diabetic or AIDS neuropathy, Complex regional pain syndrome); (d) arthritic pain; (e) MS; or (f) sickle cell (must meet chronicity criteria)
  • Evidence of tolerance/physiological dependence on opioid analgesics
  • Current opioid use disorder (DSM-IV criteria)
  • Continuous use of opioid analgesics for a minimum of 6 months prior to referral. [Note: This is consistent with minimum 6-month requirement for diagnosis of chronic pain].
  • Minimum of 2 signs/symptoms of medication mismanagement identified by the Referring MD (PROBLEMS WITH PAIN MEDS checklist)

排除标准

  • Please contact site regarding exclusion criteria for this study.

研究组 & 干预措施

1

Experimental

Methadone plus behavioral counseling consisting of adherence, self-monitoring, and motivational interviewing

干预措施: Methadone (Drug)

2

Active Comparator

Methadone plus behavioral counseling consisting of adherence

干预措施: Methadone (Drug)

结局指标

主要结局

Medication compliance and unauthorized drug use

时间窗: 24 weeks

Changes in pain severity and functioning

时间窗: 24 weeks

次要结局

  • Satisfaction with services(12 weeks)
  • Therapeutic alliance(12 weeks)

研究者

申办方类型
Nih

研究点 (1)

Loading locations...

相似试验